Proton Therapy and pharmaceutical investment company CareCapital have partnered to create a new company, Proton Therapy Global Management (PTGM).
According to the companies, PTGM will manage, design and develop a network of proton therapy centers in partnership with hospitals.
The London-based company will be managed by:
- Vernon R. Loucks, chairman of the board;
- Michael Sinclair, president and CEO;
- Ronald Anderson, chief operating officer and executive vice president; and
- Jerry Pogue, executive vice president of business development.
PTGM is currently working to fund the first five proton therapy centers in London and several U.S. cities, said the company.